Key result
3D speckle tracking echocardiography provides non-invasive and objective evaluation of early subclinical changes in left ventricular function in cancer patients undergoing chemotherapy.
Why the study?
Chemotherapy-induced cardiotoxicity is prevalent, and evaluating whether three-dimensional speckle tracking imaging aids in early detection and prediction of cardiotoxicity is needed.
Does 3D speckle tracking echocardiography aid in the early detection of cardiotoxicity in cancer patients receiving chemotherapy?
Systematic Review (n=1,991)
Does 3D speckle tracking echocardiography aid in the early detection of cardiotoxicity in cancer patients receiving chemotherapy?
3D speckle tracking echocardiography is a useful non-invasive tool for the early detection of chemotherapy-induced cardiotoxicity.
Supports 3D speckle tracking integration into cardio-oncology surveillance; confirms utility for sensitive, non-invasive LV monitoring in chemotherapy.
BACKGROUND: Chemotherapy-induced cardiotoxicity has become a prevalent complication. Regular monitoring of patients who received chemotherapy using 3D strain parameters may aid in early detection of myocardial damage and its prevention. The purpose of this study was to evaluate the effectiveness of three-dimensional speckle tracking imaging (3D-STI) in diagnosing and predicting the likelihood of cardiotoxicity. This was achieved by conducting a systematic review of original research articles. OBJECTIVES: To evaluate the role of 3D speckle tracking echocardiography in early detection of cardiotoxicity. METHODS: Relevant case control studies published prior to December 2022 were extracted to assess cardiotoxicity by 3D STE in patients after chemotherapy. RESULTS: A total of 1991 chemotherapy treated patients and control patients were included in the present review via pooling 22 studies. CONCLUSIONS: 3D speckle tracking echocardiography has the utility of non-invasive and objective evaluation of changes in left ventricular function in cancer patients undergoing chemotherapy. ROSPERO REGISTRATION NO: Study ID, CRD42023383790 on PROSPERO: International prospective register of systematic reviews.
No takes yet. Share an insight, caveat, or question.
Azzam et al. (2023) conducted a systematic review in Cancer (patients receiving chemotherapy) (n=1,991). 3D speckle tracking echocardiography (3D-STE) vs. Baseline measurements or healthy controls was evaluated on Detection of subclinical cardiotoxicity (changes in 3D strain parameters). 3D speckle tracking echocardiography provides non-invasive and objective evaluation of early subclinical changes in left ventricular function in cancer patients undergoing chemotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: